Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
684
datasets available to search
ShareScore release 0.9.0
Dataset results
684 results for “Head and Neck Squamous Cell Carcinoma”
A Study of SBRT for Squamous Cell Carcinoma of the Head and Neck
ClinicalTrials.gov study NCT04435938. IPD Sharing: Not stated. Countries: 1. Publications: 14.
Neoadjuvant Camrelizumab With Dalpiciclib for Resectable Head and Neck Squamous Cell Carcinomas
ClinicalTrials.gov study NCT06109207. IPD Sharing: Not stated. Countries: 1. Publications: 9.
Postoperative aRCH With Cisplatin Versus aRCH With Cisplatin and Pembrolizumab in Locally Advanced Head and Neck Squamous Cell Carcinoma
ClinicalTrials.gov study NCT03480672. IPD Sharing: NO. Countries: 1. Publications: 0.
E10A for the Treatment of Squamous Cell Carcinoma of the Head and Neck
ClinicalTrials.gov study NCT02630264. IPD Sharing: NO. Countries: 1. Publications: 2.
SUPREME-HN A Retrospective Cohort Study of PD-L1 in Recurrent and Metastatic Squamous Cell Carcinoma of Head and Neck (SCCHN)
ClinicalTrials.gov study NCT02543476. IPD Sharing: Not stated. Countries: 7. Publications: 1.
Neoadjuvant Tislelizumab With Afatinib for Resectable Head and Neck Squamous Cell Carcinoma
ClinicalTrials.gov study NCT05517330. IPD Sharing: NO. Countries: 1. Publications: 14.
Predictive Value of Diffusion-weighted MRI Performed in Early Post-treatment in the Occurrence of Tumor Recurrence or Progression in Head and Neck Squamous Cell Carcinoma Treated With Chemoradiotherap
ClinicalTrials.gov study NCT02862678. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Nivolumab Plus Pemetrexed for Head and Neck Squamous Cell Carcinoma
ClinicalTrials.gov study NCT04107103. IPD Sharing: NO. Countries: 1. Publications: 10.
Radiotherapy Plus Panitumumab Compared to Chemoradiotherapy With Unresected, Locally Advanced Squamous Cell Carcinoma of the Head and Neck
ClinicalTrials.gov study NCT00547157. IPD Sharing: Not stated. Countries: 0. Publications: 2.
Korean Cancer Study Group: Translational bIomarker Driven UMbrella Project for Head and Neck (TRIUMPH), Esophageal Squamous Cell Carcinoma- Part 1 (HNSCC)]
ClinicalTrials.gov study NCT03292250. IPD Sharing: UNDECIDED. Countries: 1. Publications: 1.
A Longitudinal Multi-Omic Biomarker Profiling Study of Patients With Head & Neck Squamous Cell Carcinoma (HNSCC)
ClinicalTrials.gov study NCT06163534. IPD Sharing: Not stated. Countries: 2. Publications: 28.
Role of Immune Activation in Response of Head and Neck Squamous Cell Carcinoma to Therapy
ClinicalTrials.gov study NCT01358097. IPD Sharing: Not stated. Countries: 1. Publications: 51.
Phase II Study of Concurrent C225, Cisplatin and Radiation in Stage IV Squamous Cell Carcinoma of the Head and Neck
ClinicalTrials.gov study NCT00096174. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Copanlisib in Association With Cetuximab in Patients With Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinomas Harboring a PI3KCA Mutation/Amplification and/or a PTEN Loss
ClinicalTrials.gov study NCT02822482. IPD Sharing: NO. Countries: 1. Publications: 1.
Afatinib in Patients with Fanconi Anemia (FA) and Advanced Head and Neck Squamous Cell Carcinoma (HNSCC)
ClinicalTrials.gov study NCT06648096. IPD Sharing: NO. Countries: 2. Publications: 1.
SCT200 in Combination With SCT-I10A/Paclitaxel/Docetaxel in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma
ClinicalTrials.gov study NCT05552807. IPD Sharing: NO. Countries: 1. Publications: 1.
Machine Learning-assisted immunophenotyping of peripheral blood identifies innate immune cells as best predictor of response to induction chemo-immunotherapy in head and neck squamous cell carcinoma – knowledge obtained from the CheckRad-CD8 trial
<p>Raw cell counts from peripheral blood immune phenotyping across individual patients.</p>
Genomic and single-cell characterization of patient-derived tumor organoid models of head and neck squamous cell carcinoma
Open the record for dataset details and reuse information.
Study of Dalantercept in Patients With Squamous Cell Carcinoma of the Head and Neck
ClinicalTrials.gov study NCT01458392. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study of GSK3359609 and Pembrolizumab in Programmed Death Receptor 1-ligand 1 (PD-L1) Positive Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
ClinicalTrials.gov study NCT04128696. IPD Sharing: YES. Countries: 26. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.